Skip to content

A new screening and treatment programme for diabetic retinopathy in Kerala Health services.

Implementation of a new Diabetic Retinopathy screening and treatment care pathway in the public health system in Kerala -Ornate India a UK India collaboration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/09/015868
Enrollment
1131
Registered
2018-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

Intervention1: Implementation of diabetic retinopathy screening and treatment pathway: Implementation of a new diabetic retinopathy screening and treatment care pathway in the public health system in

Sponsors

Director of Health Services representing Kerala Government
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic patients attending the Non Communicable Diseases Clinic in selected 16 Government Family Health Centres in Thiruvananthapuram,Kerala.

Exclusion criteria

Exclusion criteria: Patients with mature cataract in whom fundus examination is not possible. Patients not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
(1) Uptake of retinal screening when people with diabetes from the NCD register are invited for screening. (2) Prevalence of diabetic retinopathy (3) Prevalence of diabetic retinopathy that require treatment. (4) Proportion of people that require treatment who were treated. (5) Numbers of people averted from blindness if left untreated. Timepoint: Outcome will be determined one year from start of project

Secondary

MeasureTime frame
(1) Cost-effectiveness of the pathway calculated: The key outcome for the economic evaluation is the number of cases of blindness due to diabetic retinopathy averted as a result of the new care pathway and QALY gains arising from cases averted. (2) Describe the barriers and enhancers of the diabetic retinopathy from the qualitative data. Timepoint: One year from the start of the study

Countries

India

Contacts

Public ContactDr V Sahasranamam

Regional Institute of Ophthalmology Thiruvananthapuram

drsahasranamam@gmail.com9846020421

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026